There is no way to directly and noninvasively monitor brain oxygenation in fetuses. Fetal heart rate monitors don't work. They do not accurately and reliably predict the risk of fetal asphyxia.
Our optoacoustic technology is better because it provides absolute, accurate measurements of blood oxygenation.
Lower risk of cerebral palsy and C-section.
Decreased risk of malpractice suits and lower malpractice premiums.
Reduced hospitalization expenses.